Long-term protection against bovine leukaemia virus replication in cattle and sheep

In this report, we have evaluated the ability of two different types of liv e attenuated bovine leukaemia virus (BLV) variants (BLV DX and BLV 6073) to protect cattle and sheep against a heterologous wild-type BLV challenge. F our months after challenge, the protection of the vaccinated animals was ef fective in contrast to unvaccinated controls. However, long-term protection (18 months after challenge) was observed only in six out of seven animals, one of the vaccinated cattle being infected 12 months after challenge. A s econd prospective approach investigated the injection of naked plasmid DNA. Two sheep were injected with plasmid DNA encoding the BLV envelope protein s; the challenge virus infection was delayed but could not be completely ab rogated. Our results demonstrate that vaccines based on live attenuated vir uses and naked DNA injections are able to delay BLV infection, although com plete protection cannot be achieved. In addition, our data cast light onto the need to perform long-term vaccination trials because challenge superinf ection can occur even after apparent protection for 12 months.